tiprankstipranks
Rhinomed Limited (RHNMF)
OTHER OTC:RHNMF
Holding RHNMF?
Track your performance easily

Rhinomed Limited (RHNMF) Financial Statements

7 Followers

Rhinomed Limited Financial Overview

Rhinomed Limited's market cap is currently ―. The company's EPS TTM is $-0.025; its P/E ratio is -0.54; Rhinomed Limited is scheduled to report earnings on February 27, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Jun 21Jun 20Jun 19Jun 18
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 1.98MAU$ 2.34MAU$ 7.76MAU$ 1.42MAU$ 1.26M
Total AssetsAU$ 8.50MAU$ 6.55MAU$ 12.81MAU$ 5.87MAU$ 5.91M
Total DebtAU$ 336.74KAU$ 470.46KAU$ 588.15KAU$ 0.00AU$ 0.00
Net DebtAU$ -1.65MAU$ -1.87MAU$ -7.17MAU$ -1.42MAU$ -1.26M
Total LiabilitiesAU$ 3.46MAU$ 1.78MAU$ 1.96MAU$ 1.25MAU$ 1.14M
Stockholders EquityAU$ 5.03MAU$ 4.76MAU$ 10.86MAU$ 4.62MAU$ 4.77M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in AUD

Rhinomed Limited Earnings and Revenue History

Rhinomed Limited Debt to Assets

Rhinomed Limited Cash Flow

Rhinomed Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis